JP2014530627A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530627A5 JP2014530627A5 JP2014537358A JP2014537358A JP2014530627A5 JP 2014530627 A5 JP2014530627 A5 JP 2014530627A5 JP 2014537358 A JP2014537358 A JP 2014537358A JP 2014537358 A JP2014537358 A JP 2014537358A JP 2014530627 A5 JP2014530627 A5 JP 2014530627A5
- Authority
- JP
- Japan
- Prior art keywords
- melanoma
- cell
- vaccine
- cells
- apoptotic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161549681P | 2011-10-20 | 2011-10-20 | |
| US61/549,681 | 2011-10-20 | ||
| US201261594304P | 2012-02-02 | 2012-02-02 | |
| US61/594,304 | 2012-02-02 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014530627A JP2014530627A (ja) | 2014-11-20 |
| JP2014530627A5 true JP2014530627A5 (cg-RX-API-DMAC7.html) | 2016-02-25 |
Family
ID=48141460
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537355A Pending JP2014533938A (ja) | 2011-10-20 | 2012-10-22 | γインターフェロンを用いた抗原提示癌ワクチン |
| JP2014537358A Pending JP2014530627A (ja) | 2011-10-20 | 2012-10-22 | 抗原提示癌ワクチン |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014537355A Pending JP2014533938A (ja) | 2011-10-20 | 2012-10-22 | γインターフェロンを用いた抗原提示癌ワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20140308316A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP2768534A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2014533938A (cg-RX-API-DMAC7.html) |
| KR (2) | KR20150016200A (cg-RX-API-DMAC7.html) |
| CN (5) | CN105861437A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2012325758A1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2852960A1 (cg-RX-API-DMAC7.html) |
| HK (2) | HK1201176A1 (cg-RX-API-DMAC7.html) |
| IL (2) | IL232173A0 (cg-RX-API-DMAC7.html) |
| SG (4) | SG11201401632WA (cg-RX-API-DMAC7.html) |
| WO (2) | WO2013059778A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2865830B1 (fr) | 2004-01-30 | 2006-05-19 | Neopost Ind | Systeme d'affranchissement de courrier a mode d'impression externe securise |
| HK1201176A1 (en) * | 2011-10-20 | 2015-08-28 | Neostem Oncology, Llc | Antigen presenting cancer vaccine |
| CN103599528B (zh) * | 2013-12-04 | 2015-08-05 | 深圳市合一康生物科技股份有限公司 | 人树突状细胞疫苗的制备方法 |
| EP3169774A4 (en) * | 2014-07-17 | 2018-04-25 | Brian J. Czerniecki | Manufacturing of multi-dose injection ready dendritic cell vaccines and combination therapy for blocking her2 and her3 |
| WO2017193080A1 (en) * | 2016-05-05 | 2017-11-09 | Nantomics, Llc | Checkpoint failure and methods therefor |
| EP3582793A4 (en) * | 2017-02-17 | 2020-12-16 | Aivita Biomedical, Inc. | METHODS TO IMPROVE TUMOR IMMUNOGENICITY AND COMPOSITIONS FOR AUTOLOGOUS ANTI-CANCER IMMUNOTHERAPEUTICS USING MODIFIED TUMOR CELLS AND MODIFIED DENDRITIC CELLS |
| WO2024107624A1 (en) * | 2022-11-14 | 2024-05-23 | Shattuck Labs, Inc. | Methods of overcoming resistance to checkpoint inhibitor therapies |
| CN118441033B (zh) * | 2024-04-24 | 2025-06-20 | 广西医科大学 | HLA-DPB1*05:01在抗γ干扰素自身抗体所致获得性免疫缺陷筛查中的应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU669379B2 (en) * | 1992-09-07 | 1996-06-06 | Kyowa Hakko Kirin Co., Ltd. | Humanized antibodies |
| US5874560A (en) * | 1994-04-22 | 1999-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Melanoma antigens and their use in diagnostic and therapeutic methods |
| EP1056834A2 (en) | 1998-02-20 | 2000-12-06 | The Rockefeller University | Apoptotic cell-mediated antigen presentation to dendritic cells |
| DK1224264T3 (da) | 1999-10-15 | 2010-05-10 | Baylor Res Inst | Anvendelse af allogene cellelinjer til at belaste antigenpræsenterende celler til at fremkomme med immunresponser |
| US7015205B1 (en) * | 1999-10-18 | 2006-03-21 | St. Vincent's Hospital And Medical Center Of New York | Melanoma vaccine and methods of making and using same |
| RU2313365C2 (ru) * | 2001-11-29 | 2007-12-27 | Дандрит Байотек А/С | Фармацевтическая композиция для индукции иммунной реакции у человека |
| GB0130720D0 (en) * | 2001-12-21 | 2002-02-06 | Serono Internat S A | Proteins |
| CN1443778A (zh) * | 2002-03-13 | 2003-09-24 | 上海中信国健药业有限公司 | 一种黑色素瘤相关抗原的单克隆抗体及其用途和药物组合物 |
| US20060140983A1 (en) * | 2004-10-25 | 2006-06-29 | Baylor Research Institute | Dendritic cells loaded with heat shocked melanoma cell bodies |
| WO2007016340A2 (en) * | 2005-07-29 | 2007-02-08 | Providence Health System | Defective ribosomal products in blebs (dribbles) and methods of use to stimulate an immune response |
| WO2007051316A1 (en) * | 2005-11-07 | 2007-05-10 | British Columbia Cancer Agency | Inhibition of autophagy genes in cancer chemotherapy |
| MY160857A (en) * | 2006-02-03 | 2017-03-31 | Malaysian Palm Oil Board | A cancer vaccine |
| KR20090033375A (ko) * | 2006-06-30 | 2009-04-02 | 베일러 리서치 인스티튜트 | Ｇｍ-ｃｓｆ 및 인터페론 알파의 사용에 의해 생성되고 열처리 및 사멸된 암 세포가 로딩된 수지상 세포 |
| AR060424A1 (es) | 2007-04-11 | 2008-06-18 | Consejo Nac Invest Cient Tec | Lineas celulares , composiciones para el tratamiento de melanomas que las comprenden procedimientos para preparar las composiciones y metodos de tratamiento |
| GB0713116D0 (en) * | 2007-07-06 | 2007-08-15 | Therapeutics Ltd E | Treatment of melanoma |
| US20090041792A1 (en) * | 2007-07-19 | 2009-02-12 | Istituto Superiore Di Sanita | Dendritic cells, uses therefor, and vaccines and methods comprising the same |
| HK1201176A1 (en) * | 2011-10-20 | 2015-08-28 | Neostem Oncology, Llc | Antigen presenting cancer vaccine |
-
2012
- 2012-10-22 HK HK15101637.0A patent/HK1201176A1/xx unknown
- 2012-10-22 EP EP12842230.0A patent/EP2768534A4/en not_active Withdrawn
- 2012-10-22 JP JP2014537355A patent/JP2014533938A/ja active Pending
- 2012-10-22 WO PCT/US2012/061294 patent/WO2013059778A2/en not_active Ceased
- 2012-10-22 SG SG11201401632WA patent/SG11201401632WA/en unknown
- 2012-10-22 EP EP12841839.9A patent/EP2768519A4/en not_active Withdrawn
- 2012-10-22 CN CN201610218244.6A patent/CN105861437A/zh not_active Withdrawn
- 2012-10-22 WO PCT/US2012/061306 patent/WO2013059784A1/en not_active Ceased
- 2012-10-22 CN CN201280051799.6A patent/CN103917246A/zh active Pending
- 2012-10-22 KR KR1020147013353A patent/KR20150016200A/ko not_active Withdrawn
- 2012-10-22 CN CN201510706438.6A patent/CN105288602A/zh active Pending
- 2012-10-22 CA CA2852960A patent/CA2852960A1/en not_active Abandoned
- 2012-10-22 CA CA2852967A patent/CA2852967A1/en not_active Abandoned
- 2012-10-22 CN CN201610301904.7A patent/CN105999249A/zh active Pending
- 2012-10-22 SG SG10201602424RA patent/SG10201602424RA/en unknown
- 2012-10-22 JP JP2014537358A patent/JP2014530627A/ja active Pending
- 2012-10-22 HK HK15101635.2A patent/HK1201175A1/xx unknown
- 2012-10-22 KR KR1020147013355A patent/KR20150004791A/ko not_active Withdrawn
- 2012-10-22 CN CN201280051821.7A patent/CN103957925A/zh active Pending
- 2012-10-22 US US14/352,982 patent/US20140308316A1/en not_active Abandoned
- 2012-10-22 AU AU2012325758A patent/AU2012325758A1/en not_active Abandoned
- 2012-10-22 SG SG10201508535RA patent/SG10201508535RA/en unknown
- 2012-10-22 US US14/352,983 patent/US9555058B2/en not_active Expired - Fee Related
- 2012-10-22 AU AU2012325764A patent/AU2012325764A1/en not_active Abandoned
- 2012-10-22 SG SG11201401631VA patent/SG11201401631VA/en unknown
-
2014
- 2014-04-22 IL IL232173A patent/IL232173A0/en unknown
- 2014-04-22 IL IL232172A patent/IL232172A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530627A5 (cg-RX-API-DMAC7.html) | ||
| JP2014533938A5 (cg-RX-API-DMAC7.html) | ||
| Hailemichael et al. | Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion | |
| Padte et al. | A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates | |
| Nair et al. | Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells | |
| Alexandrescu et al. | Immunotherapy for melanoma: current status and perspectives | |
| PL2102331T3 (pl) | Szczepionka przeciwnowotworowa otrzymana z prawidłowych, chemicznie modyfikowanych komórek CD4+ | |
| EA202190587A3 (ru) | Новые пептиды и комбинации пептидов для применения в иммунотерапии гепатоклеточной карциномы (гкк) и других видов рака | |
| JP2021502414A5 (cg-RX-API-DMAC7.html) | ||
| MX2020011675A (es) | Peptidos novedosos y acidos nucleicos de los mismos contra tumores tal como los de cancer gastrico y gastrointestinal. | |
| JP2010514455A5 (cg-RX-API-DMAC7.html) | ||
| PH12015502638A1 (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
| MX2018007295A (es) | Interleucina 10 en la produccion de linfocitos t cd8+especificos para el antigeno y metodos de uso de estos. | |
| PH12020500433A1 (en) | Novel immunotherapy against several tumors, such as lung cancer, including nsclc | |
| BR112016009402A2 (pt) | Peptídeo, linfócitos t citotóxicos (ltc) ativados, método para sua produção, anticorpo, receptor de células t, ácido nucleico, célula hospedeira, uso dos mesmos, kit, método para produzir uma vacina anticâncer personalizada para um paciente individual | |
| JP2014514927A5 (cg-RX-API-DMAC7.html) | ||
| WO2012054509A3 (en) | Discovery of regulatory t cells programmed to suppress an immune response | |
| Wu et al. | Comparative study of dendritic cells matured by using IL‑1β, IL‑6, TNF‑α and prostaglandins E2 for different time span | |
| TR201905447T4 (tr) | Yeni mhc bağımsız tümörle ilişkili antijenler. | |
| JP2015506698A5 (cg-RX-API-DMAC7.html) | ||
| Masuko et al. | Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): preparation and immunological analysis of vaccine efficacy | |
| MX2023001622A (es) | Celulas dendriticas optimamente activadas que inducen una respuesta inmunologica antitumoral mayor o mejorada. | |
| US20120071860A1 (en) | Dendritic cell tumor injection (dcti) therapy | |
| MX2020011793A (es) | Nuevos peptidos y nueva combinacion de peptidos para el uso en la inmunoterapia contra el carcinoma hepatocelular (chc) y otros tipos de cancer. | |
| Yang et al. | HCA587 protein vaccine induces specific antitumor immunity mediated by CD4+ T-cells expressing granzyme B in a mouse model of melanoma |